Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Case Comprehensive Cancer Center
California Cancer Consortium
Yale University
Alliance for Clinical Trials in Oncology
Children's Oncology Group
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
NYU Langone Health
University of Arizona
Rutgers, The State University of New Jersey